Vincent Levacher
Rouen, 76000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Electro-Mediated Regioselective C2-Alkylation of N-Oxide Heteroarenes.
Journal: Organic letters
Published: July 03, 2026
Redox Heterocyclic Platforms Engineered for Brain Drug Delivery and Beyond.
Journal: Chemical record (New York, N.Y.)
Published: February 10, 2026
Recent advances of asymmetric catalytic transformations of alkylidene Meldrum's acid derivatives.
Journal: Chemical communications (Cambridge, England)
Published: April 14, 2025
Organocatalytic Strategy for a Formal 1,6-Conjugate Hydroxylation.
Journal: Organic letters
Published: October 18, 2024
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.
Journal: RSC medicinal chemistry
Published: December 12, 2023
Synthesis of α-Chloroarylacetic Acid via Electrochemical Carboxylation of α,α-Dichloroarylmethane Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: August 31, 2023
Recent Advances in Catalytic and Technology-Driven Radical Addition to N,N-Disubstituted Iminium Species.
Journal: Molecules (Basel, Switzerland)
Published: December 22, 2022
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core.
Journal: Molecules (Basel, Switzerland)
Published: November 23, 2022
Diastereoselective addition of redox active esters to azomethine imines by electrosynthesis.
Journal: Chemical communications (Cambridge, England)
Published: May 03, 2022
Organocatalytic enantioselective synthesis of β-amino sulfonic acid derivatives.
Journal: Chemical communications (Cambridge, England)
Published: August 02, 2021
Organocatalytic Multicomponent Synthesis of α/β-Dipeptide Derivatives.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 10, 2020
Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy.
Journal: Molecules (Basel, Switzerland)
Published: March 04, 2019
Last Updated: 09/26/2026